Pediatrix Medical Group, Inc. (MD): Long-Term Debt

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2019-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$611.20M
As of 2024-12-31
-14.8%
3-year compound annual growth
-18.5%
5-year compound annual growth
$1.97B2013-12-31: $27.00M2014-12-31: $567.45M2015-12-31: $1.27B2016-12-31: $1.70B2017-12-31: $1.85B2018-12-31: $1.97B2019-12-31: $1.70B2020-12-31: $1.70B2021-12-31: $989.70M2022-12-31: $637.20M2023-12-31: $622.20M2024-12-31: $611.20M$611.20M
2013-12-31 Long-Term Debt (USD) 2024-12-31
Period endedLong-Term DebtChange YoYSource filing
2024-12-31$611.20M-1.8%2025-02-20, Balance as of period end
2023-12-31$622.20M-2.4%2025-02-20, Balance as of period end
2022-12-31$637.20M-35.6%2024-02-20, Balance as of period end
2021-12-31$989.70M-41.8%2023-02-17, Balance as of period end
2020-12-31$1.70B0.0%2022-02-17, Balance as of period end
2019-12-31$1.70Bn/c2021-02-18, Balance as of period end
2018-12-31$1.97B+6.7%2020-02-20, Balance as of period end
2017-12-31$1.85B+8.7%2019-02-14, Balance as of period end
2016-12-31$1.70B+33.7%2018-02-14, Balance as of period end
2015-12-31$1.27B+123.9%2017-02-10, Balance as of period end
2014-12-31$567.45Mn/m2016-02-11, Balance as of period end
2013-12-31$27.00Mn/a2015-02-09, Balance as of period end